David Calvo-rekin lankidetzan egindako argitalpenak (7)

2018

  1. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing

    Europace, Vol. 20, Núm. FI1, pp. f64-f71

2017

  1. An elderly Jervell and Lange-Nielsen patient heterozygous compound for two new KCNQ1 mutations

    American Journal of Medical Genetics, Part A, Vol. 173, Núm. 3, pp. 749-752

  2. Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT

    Epigenomics, Vol. 9, Núm. 8, pp. 1049-1057

2016

  1. KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in the Spanish Renastur cohort

    Molecular and Cellular Endocrinology, Vol. 427, pp. 86-91

  2. Surveillance after cardiac arrest in patients with Brugada syndrome without an implantable defibrillator: An alarm effect of the previous syncope

    International Journal of Cardiology, Vol. 218, pp. 69-74

2015

  1. Time-dependent responses to provocative testing with flecainide in the diagnosis of Brugada syndrome

    Heart Rhythm, Vol. 12, Núm. 2, pp. 350-357

2009

  1. Hypertrophic cardiomyopathy and athlete's heart: A tale of two entities

    European Journal of Echocardiography, Vol. 10, Núm. 1, pp. 151-153